Waters to Buy Back Stock | GenomeWeb

NEW YORK (GenomeWeb News) – Waters today said that its board of directors has authorized the firm to repurchase up to $500 million of its outstanding common stock over the next 24 months.

The firm's previous $500 million share repurchase program, which began in February 2007, had recently expired. Waters said that that repurchase program was "substantially completed."

It said that it would make purchases of its shares through open-market transactions.

Waters' shares were trading down 1 percent at $34.70 in early Monday trade on the New York Stock Exchange.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.